Study of BD ORC Original Absorbable Hemostat vs. Surgicel® Original Absorbable Hemostat
-
StatusAccepting Candidates
-
Age22 Years - 99 Years
-
SexesAll
-
Healthy Volunteers
Description
This study will evaluate the safety and efficacy of BD ORC Original Absorbable Hemostat when compared to a currently marketed ORC hemostat (Surgicel® Original Absorbable Hemostat) for achieving hemostasis at target bleeding sites (TBSs) as an adjunctive hemostat in planned, open/minimally invasive general surgical procedures
Details
Protocol number | DVL-HEM-001 |
Eligibility
Inclusion Criteria:
- Males or females 22 years of age or older at the time of consent
- Is undergoing a planned open/minimally invasive surgical procedure in general surgery
Exclusion Criteria:
- Is known to be pregnant or plans to become pregnant during the study period
- Has an uncontrolled bleeding disorder
- Has a documented clinical history of bleeding or coagulation disorder or disease
Has received hemodialysis within 30 days before surgery or is planned to receive hemodialysis within 45 days post-surgery
Has documented severe congenital or acquired immunodeficiency or is currently being treated with immunosuppressive drugs
Has been treated or is planning to be treated with another investigational drug or device within 30 days of surgery
Has taken blood thinners or chronic steroids
Lead researchers
-
Shane Hester, DO, FACS, DABSSurgical Critical Care Physician
-
-
Jana M Sacco, MDHernia and Abdominal Wall Surgeon
Participate in a study
Here are some general steps to consider when participating in a research study:
-
Step1
Contact the research team
Call or email the research team listed within the specific clinical trial or study to let them know that you're interested. A member of the research team, such as the researcher or study coordinator, will be available to tell you more about the study and to answer any questions or concerns you may have.
Primary contact
-
Step2
Get screened to confirm eligibility
You may be asked to take part in prescreening to make sure you are eligible for a study. The prescreening process ensures it is safe for you to participate. During the prescreening process, you will be asked some questions and you may also be asked to schedule tests or procedures to confirm your eligibility.
-
Step3
Provide your consent to participate
If you are eligible and want to join the clinical trial or study, a member of the research team will ask for your consent to participate. To give consent, you will be asked to read and sign a consent form for the study. This consent form explains the study's purpose, procedures, risks, benefits and provides other important information, such as the study team's contact information.
-
Step4
Participate
If you decide to participate in a clinical trial or study, the research team will keep you informed of the study requirements and what you will need to do to throughout the study. For some trials or studies, your health care provider may work with the research team to ensure there are no conflicts with other medications or treatments.